The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Review Article
Mechanisms of Disease
PreviousPrevious
Volume 351:2087-2100 November 11, 2004 Number 20
NextNext

Intermediate Filament Proteins and Their Associated Diseases
M. Bishr Omary, Ph.D., M.D., Pierre A. Coulombe, Ph.D., and W.H. Irwin McLean, Ph.D., D.Sc.

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-PubMed Citation
The cytoskeleton consists of three abundant families of fibrillary proteins: microfilaments, microtubules, and intermediate filaments.1,2 Intermediate filament proteins derive their name from their diameter, which is intermediate between the diameters of microfilaments and microtubules.1,2 They differ from actin microfilaments and tubulin microtubules in their large number, their distribution in the cytoplasm and nucleus, their diverse primary structure (Table 1), their nonpolar architecture, their relative insolubility, and their nucleotide-independent dynamics.1,2,3 The human genome contains at least 65 functional genes encoding intermediate filament proteins, placing them among the 100 largest gene families in humans.4 More than 30 diseases are related . . . [Full Text of this Article]

General Features of Intermediate Filaments

Structure

Regulation

Functions

Shared and Tissue-Specific Functions

Disease-Related Aspects

Cytoplasmic Intermediate Filament–Related Diseases

Diseases of the Skin and Epithelium

Diseases of the Hair

Myopathies and Lens Disorders

Neurodegenerative Disorders

Interacting-Protein–Related Diseases

Pathogenesis of Cytoplasmic Intermediate Filament–Related Diseases

Organization and Redundancy

Cell Fragility

Disruption of Organelle and Protein Targeting

Genetics, Epigenetics, and Environment

Laminopathies

Diseases

Pathogenesis

Therapeutic Approaches

Future Perspectives


Source Information

From the Department of Medicine, Palo Alto Veterans Affairs Medical Center and Stanford University, Palo Alto, Calif. (M.B.O.); the Departments of Biological Chemistry and Dermatology, Johns Hopkins University School of Medicine, Baltimore (P.A.C.); and the Human Genetics Unit, University of Dundee, Ninewells Hospital and Medical School, Dundee, United Kingdom (W.H.I.M.).

Address reprint requests to Dr. Omary at the Palo Alto VA Medical Center, 3801 Miranda Ave., Mail Code 154J, Palo Alto, CA 94304.


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.